Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population
TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - acpjournals.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
[引用][C] Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
TG Simon, AS Duberg, S Aleman, H Hagstrom… - Annals of Internal …, 2019 - cir.nii.ac.jp
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic
Viral Hepatitis: Results From a Nationwide Swedish Population | CiNii Research CiNii 国立 …
Viral Hepatitis: Results From a Nationwide Swedish Population | CiNii Research CiNii 国立 …
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
TG Simon, AS Duberg, S Aleman, H Hagstrom… - 2019 - saigaiin.sakura.ne.jp
Compared with matched nonusers, 10-year HCC risk was significantly lower among
lipophilic statin users (8.1% vs. 3.3%; absolute risk difference [RD],− 4.8 percentage points …
lipophilic statin users (8.1% vs. 3.3%; absolute risk difference [RD],− 4.8 percentage points …
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
TG Simon, AS Duberg, S Aleman… - Annals of Internal …, 2019 - diva-portal.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …
Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population.
TG Simon, AS Duberg, S Aleman, H Hagstrom… - 2019 - cabidigitallibrary.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
[HTML][HTML] Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - ncbi.nlm.nih.gov
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
TG Simon, AS Duberg, S Aleman… - Annals of Internal …, 2019 - europepmc.org
Background Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
TG Simon, AS Duberg, S Aleman… - Annals of Internal …, 2019 - europepmc.org
Background Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …
mortality in chronic hepatitis B or C virus infection is unknown. Objective To assess the …